Rat models of genetic absence epilepsy: What do EEG spike-wave discharges tell us about drug effects?

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue SUPPL. D, 2002, Pages 65-70

  Van Luijtelaar, E L J M ^a   Drinkenburg, W H I M ^b   Van Rijn, C M ^a   Coenen, A M L ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ETIRACETAM; ETOMIDATE; FENTANYL DERIVATIVE; FLUANISONE; GABAPENTIN; LAMOTRIGINE; LORECLEZOLE; OPIATE RECEPTOR; OPIATE RECEPTOR AFFECTING AGENT; PROGABIDE; REMACEMIDE; TIAGABINE; ANTICONVULSIVE AGENT;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EVALUATION; GENETIC ANALYSIS; GENETIC MODEL; NONHUMAN; RAT; RAT STRAIN; RELIABILITY; SPIKE WAVE; VALIDATION PROCESS; ACTION POTENTIAL; ANIMAL; DISEASE MODEL; ELECTROENCEPHALOGRAPHY; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; HUMANS; RATS;

EID: 0036454322     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Marescaux, C., Micheletti, G., Vergnes, M., Depaulis, A., Rumbach, L., Warter, J. A model of chronic spontaneous petit mallike seizures in the rat: Comparison with pentylenetetrazol-induced seizures. Epilepsia 1984, 25: 326-31.
2. Marescaux, C., Vergnes, M., Depaulis, A. Genetic absence epilepsy in rats from Strasbourg - A review. J Neural Transm 1992, 35: 37-69.
3. van Luijtelaar, E., Coenen, A. Two types of electrocortical paroxysms in an inbred strain of rats. Neurosci Lett 1986, 70: 393-7.
4. Coenen, A., Drinkenburg, W., Inoue, M., van Luijtelaur, E. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res 1992, 75-86.
5. Danober, L., Deransart, C., Depaulis, A., Vergnes, M., Marescaux, C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Progr Neurobiol 1998, 55: 27-57.
6. Drinkenburg, W., van Luijtelaar, E., van Schaijk, W., Coenen, A. Aberrant transients in the EEG of epileptic rats: A spectral analytical approach. Physiol Behav 1993, 54: 779-83.
7. Coenen, A., van Luijtelaar, E. The WAG/Rij model for absence epilepsy: Age and sex factors. Epilepsy Res 1987, 1: 297-301.
8. van Luijtelaar, E., Coenen, A. The WAG/Rij model for generalized absence seizures. In: Advances in Epileptology Vol. 17. Manelis, J. et al. (Eds.). Raven Press 1989, 78-83.
9. Midzianovskaia, I., Kuznetsova, G., Coenen, A., Spirodov, A., van Luijtelaar, E. Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats. Brain Res 2001, 911: 62-70.
10. Meeren, H., Pijn, J., van Luijtelaar, E., Coenen, A., Lopes da Silva, F. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 2002, 22: 1480-95.
11. Coenen, A., Drinkenburg, W., Peeters, A., Vossen, J., van Luijtelaar, E. Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. Neurosci Biobehav Rev 1991, 15: 259-63.
12. Drinkenburg, W., Coenen, A., Vossen, J., van Luijtelaar, E. Spikewave discharges and sleep-wake states in rats with absence epilepsy. Epilepsy Res 1991, 9: 218-224.
13. Gloor, P. Neurophysiological bases of generalized seizures termed centrencephalic. In: The Physiopathogenesis of the Epilepsies. Gastaut, H., Jasper, H.H., Bancaud, J., Waltregny, A. (Eds.). Charles C. Thomas: Springfield, IL, 1969, 209-36.
14. Kostopoulos, G. Spike-and-wave discharges of absence seizures as a transformation of sleep spindles: The continuing development of a hypothesis. Clin Neurophysiol 2000, 111: S27-38.
15. Gandolfo, G., Romettino, S., Gottesmann, C., van Luijtelaar, G., Coenen, A. Genetically epileptic rats show a pronounced intermediate stage of sleep. Physiol Behav 1990, 47: 213-5.
16. Gottesmann, C. The transition from slow-wave sleep to paradoxical sleep: Evolving facts and concepts of the neurophysiological processes underlying the intermediate stage of sleep. Neurosci Biobehav Rev 1996, 20: 367-87.
17. van Luijtelaar, E. Spike-wave discharges and sleep spindles in rats. Acta Neurobiol Exp 1997, 57: 113-21.
18. Peeters, B., Spooren, W., van Luijtelaar, E., Coenen, A. The WAG/Rij model for absence epilepsy: Anticonvalsant drug evaulation. Neurosci Res Comm 1988, 2: 93-7.
19. Micheletti, B., Vergnes, M., Marescaux, C, et al. Antiepileptic drug evaluation in a new animal model: Spontaneous petit mal epilepsy in the rat. Arzneim Forsch 1985, 35, 483-5.
20. Peeters, B., van Rijn, C., Vossen. J., Coenen, A. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy. EEG and behaviour, in the WAG/Rij inbred strain of rats. Life Sciences 1989, 45: 1171-6.
21. Coenen, A., Blezer, E., van Luijtelaar, E. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res 1995, 21: 89-94.
22. Knake, S., Hamer, H., Schomburg, U., Oertel, W., Rosenow, F. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 1999, 8: 314-7.
23. Kelly, K. Gabapentin. Antiepileptic mechanisms of action. Neuropsychobiology 1998, 38: 139-44.
24. Trudeau, V., Myers, S., LaMoreaux, L., Anhut, H., Garofalo, E., Ebersole, J. Gabapentin in naive chilhood absence epilepsy: Results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996, 11: 470-5.
25. Stefan, H., Plouin, P., Fichsel, H., Jalin, C., Burr, W. Progabide for previously untreated absence epilepsy. Epilepsy Res 1988, 2: 132-6.
26. van Luijtelaar, E., Coenen, A. Effects of remacemide and its metabolite FPL 12495 on spike-wave discharges, electroencephalogram and behaviour in rats with absence seizures. Neuropharmacology 1995, 34: 419-25.
27. van Rijn, C., Weyn Banningh, E., Coenen, A. Effects of lamotrigine on absence seizures in rats. Pol J Pharmacol 1994, 46: 467-70.
28. Dalby, N., Nielsen, E. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 1997, 28: 63-72.
29. Gericke, C., Picard, F., de Saint-Martin, A., Strumia, S., Marescaux, C., Hirsch, E. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: A video-EEG-controlled, open study. Epileptic Disord 1999, 1: 159-63.
30. Panayiotopoulos, C. Benign childhood epileptic syndromes with occipital spikes: New classification proposed by the International League Against Epilepsy. J Child Neurol 2000, 15: 548-52.
31. Peeters, B., Ramakers, G., Ellenbroek, B., Vossen, J., Coenen, A. Interactions between NMDA and nonNMDA receptors in nonconvulsive epilepsy in the WAG/Rij inbred strain. Brain Res Bull 1994, 33: 715-8.
32. Kaminski, R., van Rijn, C., Turski, W., Czuczwar, S., van Luijtelaar, E. AMPA and GABA (B) receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur J Pharmacol 2001, 430: 251-9.
33. Gower, A., Hirsch, E., Boehrer, A., Noyer, M., Marescaux, C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 1995, 22: 207-13.
34. A receptor complex. Neurosci Res Communications 1993, 12: 57-60.
35. Ate, N., van Luijtelaar, E., Drinkenburg, W., Vossen, J., Coenen, A. Effects of loreclezole on epileptic activity and on EEG and behaviour in rats with absence seizures. Epilepsy Res 1992, 13: 43-8.
36. Laso, W., Przewocka, B., Coenen, A., Przewocki, R., van Luijtelaar, E. The role of the opioid system in absence epilepsy in rats. In: Typical Absences and Related Epileptic Syndromes. Duncan, J., Panayiotopoulos, C. (Eds.). Churchill Communications Europe: London 1995, 59-68.
37. Frey, H., Voigts, M. Effects of psychotropic agents on a model of absence epilepsy in rats. Neuropharmacology 1991, 30: 651-6.
38. Laso, W., Przewocka, B., Coenen, A., Przewocki, R., van Luijtelaar, E. Effects of mu and delta opioid receptor agonists and antagonists on absence epilepsy in WAG/Rij rats. Neuropharmacology 1994, 33: 161-6.
39. Przewocka, B., Laso, W., Machelska, H., van Luijtelaar, G., Coenen, A., Przewocki, R. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci Lett 1995, 86: 131-4.
40. Inoue, M., Ate, N., Vossen, J., Coenen, A. Effects of the neuroleptanalgesic fentanyl-flutanisone (Hypnorm) on spike-wave discharges in epileptic rats. Pharmacol Biochem Behav 1994, 48: 547-51.
41. Duysens, J., Inoue, M., van Luijtelaar, E., Dirksen, R., Coenen, A. Facilitation of spike-wave activity by the hypnotic etomidate in a rat model for absence epilepsy. Intern J Neuroscience 1991, 57: 213-7.
42. A receptor function. Trends Pharmacol Sci 1995, 16: 295-303.
43. Budziszewska, B., van Luijtelaar, G., Coenen, A., Leskiewicz, M., Laso, W. Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat. Epilepsy Res 1999, 33: 23-9.
44. Gelmers, H., Gorter, K., de Weerdt, C., Wieser, H. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988, 318: 203-7.
45. van Luijtelaar, E., Ates, N., Coenen A. Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia 1995, 36: 86-92.
46. Lees, K. Cerestat and other NMDA antagonists in ischemic stroke. Neurology, 1997 49: S66-99.
47. Filakovszky, J., Gerber, K., Bagdy, G. A serotonin-IA receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. Neurosci Lett 1999, 261: 89-92.
48. Peeters, B., van Rijn, C., van Luijtelaar, E., Coenen, A. Antiepileptic and behavioural actions of MK-801 in an animal model of spontaneous absence epilepsy. Epilepsy Res 1989, 3: 178-81.
49. 2+ channels and in gerbil global cerebral ischaemia. Eur J Pharmacol 1996, 299: 103-12.